menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL

    INDPHARMAPOST

    Glenmark Pharma Shares Up 2% on Rolling Out Lacosamide Solution

    BUSINESS STD

    Glenmark Pharma arm launches seizure drug in US

    BUSSINESS STD

    Somerset`s Generics Lacosamide Receives Approval in US

    FDA

    Chartwell RX Generic Lacosamide Receives Approval in the U.S.

    FDA

    Medley Pharma`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Amneal Pharm Generic Lacosamide Receives Approval in the U.S.

    FDA

    Dr. Reddy`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Aucta debuts generic Vimpat

    DRUG STORE NEWS

    Aucta Pharma Launches First Once-Daily Lacosamide ER Capsule

    PR NEWSWIRE

    Hainan Poly`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Aurobindo Pharma`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Congratulations to Shandong on obtaining the CEP certificate for "Lacosamide"

    PRESS RELEASE

    ​​The first domestic imitation of Lacosamide Oral Solution is approved.

    PRESS RELEASE

    Congratulations to Long Nuo Pharma"Lacosamide" for obtaining the CEP certificate

    PRESS RELEASE

    Extrovis` Lacosamide Adroiq (lacosamide) Receives Approval in Europe

    EMA

    Aurobindo`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Actavis` Generic Lacosamide Receives Approval in the U.S.

    FDA

    Fresenius Targets Treatment of Seizures with Generic Lacosamide Injection

    BUSINESSWIRE

    UCB`s Vimpat Receives Approval in Europe

    EMA

    Apotex`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Gland`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Aspiro`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Novitium`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Accord healthcare`s Generic Lacosamide Receives Approval in the US

    FDA

    Breckenridge Launches Lacosamide Tablets Manufactured by MSN Laboratories

    PRNEWSWIRE

    The first imitation of lacosamide oral solution in China was approved

    PRESS RELEASE

    FDA approves Indoco Remedies, Lacosamide injection

    ET HEALTH

    Indoco Remedies`s Generic Lacosamide Receives Approval in US

    FDA

    New Launch: Tiefenbacher Pharma Successfully Launches First Generic Version

    PRESS RELEASE

    Indoco`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Sciegen Pharms` Generic Lacosamide Receives Approval in the U.S.

    FDA

    Sun Pharma`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Glenmark Pharms` Generic Lacosamide Receives Approval in the U.S.

    FDA

    Alembic Pharms` Generic Lacosamide Receives Approval in the U.S.

    FDA

    MSN Labs` Generic Lacosamide Receives Approval in the U.S.

    FDA

    Amneal Pharm`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Hetero Labs` Generic Lacosamide Receives Approval in the U.S.

    FDA

    Indoco`s Generic Lacosamide Receives Approval in the U.S.

    FDA

    Alkem Labs`s Generic Lacosamide Receives Approval In US

    FDA

    Alkem Labs`s Generic Lacosamide Receives Approval In US

    FDA

    UCB strikes 2 gene therapy deals to build its pipeline

    BIOPHARMADIVE

    Phase 3 data on VIMPAT® (lacosamide) CV in tonic-clonic seizures published

    BIOSPACE

    MSN Labs Generic Lacosamide Receives Tentative Approval In US

    FDA

    UCB Presents New Data Demonstrating Commitment to Epilepsy

    PR NEWSWIRE

    Letters and drug alerts sent to healthcare professionals in July 2019

    GOVUK

    AZ bags two extensions in latest CHMP decisions

    PHARMATIMES

    Hetero Lab III`s Generic Lacosamide Receives Tentative Approval in US

    FDA

    Epilepsy Patients Treated With Adjunctive FYCOMPA® (perampanel) CIII

    PR NEWSWIRE

    Zydus Pharms USA`s Generic Lacosamide Receives Tentative Approval in US

    FDA

    Apotex`s Generic Lacosamide Receives Tentative Approval in US

    FDA

    Aurobindo Pharma Ltd.’s Generic Lacosamide Receives Tentative Approval in the US

    FDA

    UCB’s Vimpat gets NHS green light in Wales

    PHARMA TIMES

    Accord Healthcare`s Lacosamide Accord (lacosamide) Receives Approval In Europe

    EMA

    Daiichi Sankyo, UCB Japan announce Vimpatò tablets approved for monotherapy

    PHARMABIZ

    Generic Giants Ask Fed. Circ. To Nix Vimpat Patent

    LAW360

    Argentum Persists in Challenging the

    PR NEWSWIRE

    Teva`s Generic Lacosamide Receives Approval In US

    FDA

    Accord`s Generic Lacosamide Receives Tentative Approval In US

    FDA

    Lacosamide has potential as first-line monotherapy for newly diagnosed epilepsy

    PHARMACEUTICAL JOURNAL

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.